Laddar...
Updated Perspectives on the Management of Multiple Myeloma in Older Patients: Focus on Lenalidomide
Multiple myeloma is a hematologic malignancy that predominantly affects older adults, with a median age at diagnosis of 70 years old. A mainstay of multiple myeloma treatment is lenalidomide, which is an immunomodulatory drug (IMiD) that changed the treatment paradigm for multiple myeloma. This is p...
Sparad:
| I publikationen: | Clin Interv Aging |
|---|---|
| Huvudupphovsmän: | , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Dove
2020
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7210019/ https://ncbi.nlm.nih.gov/pubmed/32440105 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CIA.S196087 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|